Cesare Aragona

No ORCID on file · 3 papers in corpus
other 2025
A retrospective study "myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients."
Health economics review ·doi:10.1186/s13561-025-00609-8

BACKGROUND: Fertility care represents a financial burden on patients and healthcare services alike and can represent a barrier to entry for many couples. Controlled ovarian stimulation (COH) is routinely used as part of in vitro fertilizati…

review 2024
d-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI)
Gynecologic and obstetric investigation ·doi:10.1159/000536081

BACKGROUND: d-Chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders. OBJECTIVES: This perspective seeks to explore the…

nonrandomized-trial 2023
D-Chiro-Inositol in Endometrial Hyperplasia: A Pilot Study
International journal of molecular sciences ·doi:10.3390/ijms241210080

Endometrial hyperplasia is a threatening pathology driven by unopposed estrogen stimulus. Moreover, insulin may act on the endometrium, prompting further growth. We aimed at assessing whether D-chiro-Inositol, an insulin sensitizer with est…